title: Is there a diminishing role for surgery for Merkel cell carcinoma of the skin? a review of current management.
abstract: Merkel cell carcinoma is a highly malignant skin tumour that must be managed in a multidisciplinary forum. Excisional biopsy of the primary is recommended and this should be followed by postoperative radiotherapy to the primary site, in-transit areas and the draining lymph nodes. The tumour is quite radiosensitive and radiation doses of the order of 50 Gy offer high levels of local control. Resection margins of 3 cm are not required provided postoperative radiotherapy is used. In the event of inoperable disease, patient refusal of surgery or a frail patient, radiotherapy should be used as the sole treatment modality, with high likelihood of achieving local control. Patients with involved nodes have a higher risk of distant disease. Traditionally, involved nodes have been managed with resection but, currently, there are protocols exploring the use of synchronous chemoradiotherapy as definitive treatment. Although adjuvant chemotherapy has been used in this setting to reduce the risk of distant seeding, the benefits at this stage have not been confirmed conclusively. The presence of distant disease carries a grave outlook and responses to chemotherapy occur frequently, but are usually shortlived.
authors.affiliation: Division of Oncology, Mater Queensland Radium Institute, Brisbane, Australia. M.Poulsen@mailbox.uq.edu.au
authors.forename: M
authors.initials: M
authors.lastname: Poulsen
authors.forename: J
authors.initials: J
authors.lastname: Harvey
mesh_terms: D015266:Carcinoma, Merkel Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D006801:Humans; D017063:Outcome Assessment, Health Care; D012878:Skin Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*